Dot Decimal
Focus: Dot Decimal develops custom patient-specific cancer treatment devices, operating in the specialized oncology space with a focused early-stage biotech model.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Open Jobs
3
Should You Work at Dot Decimal?
AI assessmentDot Decimal is a high-risk, early-stage precision oncology device play suitable only for risk-tolerant candidates seeking founding-team experience or those willing to bet on an unproven technology platform.
Why Work Here
- Ground-floor opportunity in an emerging precision oncology device company with differentiated patient-specific treatment approach
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dot Decimal
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.